Accessibility Menu
Hinge Health logo

Hinge Health(NYSE) HNGE

Market Cap$6.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)+113%
5 YearN/A
1 Year+48%
1 Month+1%
$89.02
+11.16%
+8.94Today
After hours$89.32+$0.30 (+0.34%)
Hinge Health last closing stock price
MetricPriceDate
Last closeUSD 89.332026-08-07
Hinge Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+19.57%USD 74.712026-07-31
1 month+0.94%USD 88.502026-07-08
3 month+59.46%USD 56.022026-05-08
Year to date+92.31%USD 46.452025-12-31
1 year+48.02%USD 60.352025-08-07
Since inception+113.21%USD 37.562025-05-22

Hinge Health Financials at a Glance

Market Cap

$6.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$720.06M

Net Income (TTM)

$109.07M

EPS (TTM)

$1.30

P/E Ratio

68.79

Dividend

$0.00

Beta (Volatility)

0.32 (Low)

Price

$89.02

Volume

2,562,874.19

Open

$80.38

Previous Close

$89.33

Daily Range

$80.36 - $90.40

52-Week Range

$30.08 - $91.50

Estimated Earnings Date

Nov 3, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hinge Health

Hinge Health helps people treat joint and muscle pain. It uses software and wearables to provide therapy at home. This technology helps workers through their employer health plans.

Helping People Move Better

  • Chronic Care: Personalized exercise programs for long-term pain; provides access to licensed physical therapists and health coaches.
  • Enso Wearable: Small device delivering electrical nerve stimulation; offers a drug-free way to manage muscle and joint pain.
  • HingeSelect: High-performance network of in-person doctors; triages members to pre-vetted specialists for advanced care and imaging.
  • Women's Pelvic Health: Focused support for pregnancy, postpartum, and menopause; treats specific pelvic disorders through movement and education.

Where is Hinge Growing?

  • Expanded international operations into six countries including Canada and the United Kingdom in 2024.
  • Introduced HingeSelect in 2025 to connect digital users with in-person medical providers.
  • Rolled out TrueMotion AI technology to track member exercises using mobile device cameras.
  • Formed partnerships with healthcare entities like Accolade, Inc. and Teladoc Health, Inc. to simplify sales.

The Software Advantage

The company uses AI-powered camera technology to track movement and provide real-time exercise feedback. This software-led model reduced the human labor hours needed for traditional physical therapy by 97% in 2025.

By the Numbers

  • Revenue reached $170.7 million in Q4 2025, up 45.6% from Q4 2024.
  • Gross profit was $144 million in Q4 2025, up 49.9% year-over-year.
  • Net income hit $32.1 million in Q4 2025, up 18.4% from the previous year.
  • Free cash flow rose to $63.5 million in Q4 2025, up 70.2% year-over-year.

Bottom Line

Hinge Health has evolved from a digital exercise app to a comprehensive system for musculoskeletal health. Its transition toward automated care and in-person networks allows it to address a broad range of patient needs.

AI Generated • Apr 25, 2026

Industry

Healthcare Providers and Services

Employees

143

CEO

Daniel Perez, PhD

Headquarters

San Francisco, CA 94105, US

HNGE Financials

Key Financial Metrics (TTM)

Gross Margin

84.52%

Operating Margin

13.01%

Net Income Margin

15.15%

Return on Equity

30.25%

Return on Capital

-141.34%

Return on Assets

13.18%

Earnings Yield

1.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

74.00M

Volume

2.56M

Avg. Volume

1.93M

Financials (TTM)

Gross Profit

$608.59M

Operating Income

$93.67M

EBITDA

$102.89M

Operating Cash Flow

$290.79M

Capital Expenditure

-$3.46M

Free Cash Flow

$287.33M

Cash & ST Invst.

$389.39M

Total Debt

$5.89M

Hinge Health Performance Analysis

Hinge Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-12-31USD 292,730,000N/A
20242024-12-31USD 390,404,00033.4%
20252025-12-31USD 587,860,00050.6%
Hinge Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3010.9%
Q42025-12-3110.7%
Q12026-03-316.8%
Q22026-06-3016.7%
Hinge Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-12-31USD -1.39N/A
20242024-12-31USD -0.15-89.0%
20252025-12-31USD -5.363401.0%
Hinge Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3099.7%
Q42025-12-311681.2%
Q12026-03-3110.8%
Q22026-06-3029.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$212.82M

+53.0%

Gross Profit

$183.95M

+88.2%

Gross Margin

86.44%

N/A

Market Cap

$6.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$46.22M

N/A

Employees

143

N/A

Net Income

$43.69M

+107.6%

EBITDA

$45.49M

+107.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$389.39M

-5.8%

Total Debt

$5.89M

-40.9%

Accounts Receivable

$125.43M

+26.3%

Inventory

$16.77M

+19.9%

Long Term Debt

$1.63M

-72.4%

Short Term Debt

$4.25M

+5.1%

Return on Assets

13.18%

N/A

Return on Invested Capital

27.08%

N/A

Free Cash Flow

$99.56M

+441.1%

Operating Cash Flow

$101.41M

+401.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LNTHLantheus Holdings, Inc.
$100.95-0.12%
OSCROscar Health, Inc.
$27.90+5.12%
IMVTImmunovant, Inc.
$39.95+0.53%
DYNDyne Therapeutics, Inc.
$26.25+1.43%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$133.11+0.16%
TTDThe Trade Desk
$13.80-0.22%
NVDANvidia
$223.96+0.02%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$82.76+0.00%

Questions About HNGE

What is the current price of Hinge Health?

Hinge Health is trading at $89.33 per share.

What is the 52-week range for Hinge Health?

Over the past 52 weeks, Hinge Health has traded between $30.08 and $91.50.

How much debt does Hinge Health have?

As of the most recent reporting period, Hinge Health reported total debt of $5.89M.

How much cash does Hinge Health have on hand?

Hinge Health reported $286.22M in cash and cash equivalents in its most recent financial results.

What is Hinge Health’s dividend yield?

Hinge Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.